Support for abortion and for research on the comparative effectiveness of disease treatments could be two stumbling blocks to the confirmation of US President Barack Obama's choice of Kathleen Sebelius (Democrat Governor, Kansas) for the post of Secretary of Health and Human Services (Marketletter March 9).
This is the last Cabinet appointment still to be cleared through the normal congressional system. In a Senate Finance Committee meeting, eight of 10 Republican members opposed Gov Sebelius' nomination, although there was overall support in a 15-to-eight vote. A full Senate vote is now expected next week.
One of the opposers was Senator Jon Kyl (Republican, Arizona) who, according to the Washington Post, fears that her evidence-based approach, coupled with information on price, could lead to rationing of health care. Senate Minority Leader Mitch McConnell (Republican, Kentucky) objected, saying that lawmakers need more time to consider her "fairly contentious" selection.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze